Progesterone-Induced Stimulation of Mammary Tumorigenesis Is Due to the Progesterone Metabolite, 5α-Dihydroprogesterone (5αP), and Can Be Suppressed by the 5α-Reductase Inhibitor, Finasteride

    John S. Wiebe, Martín Enrique Hernández Rivas, María Florencia Mercogliano, Patricia V. Elizalde, Roxana Schillaci
    Image of study
    TLDR Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.
    The study found that the progesterone metabolite 5α-dihydroprogesterone (5αP) is responsible for the stimulation of mammary tumorigenesis induced by progesterone. This effect can be suppressed by the 5α-reductase inhibitor, finasteride. The findings suggest that targeting 5αP may be a potential therapeutic strategy for breast cancer treatment.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 112 results

    Related Research

    1 / 1 results